A population-based cohort study defines prognoses in severe chronic kidney disease
- PMID: 29525394
- DOI: 10.1016/j.kint.2017.12.013
A population-based cohort study defines prognoses in severe chronic kidney disease
Abstract
In older people with chronic kidney disease (CKD) and comorbidities, the risk of death or disability may overshadow the risk of kidney failure. To help refine this we did a retrospective population-based cohort study to evaluate the relative likelihood of adverse outcomes as functions of age and comorbidity burden among 47,228 adults with severe non-dialysis dependent CKD. We identified comorbidities using 29 validated algorithms applied to administrative data and assessed death, end-stage renal disease (ESRD), cardiovascular disease (CVD) events, and long-term care. Over five years of follow-up, 53.4% of participants died, 24.1% had a CVD event, 14.3% were placed into long-term care and 5.3% developed ESRD. Death was 145 times more likely and 11 times more likely than ESRD for participants aged 80 years or more and 60-79 years, respectively; long-term care was 30 times more likely and 1.7 times as likely as ESRD for participants aged 80 years or more and 60-79 years, respectively. Increasing comorbidity burden was similarly associated with increased risk of death and long-term care placement but reduced the likelihood of ESRD, and the risks of increasing age were similarly incremental. Thus, among patients with severe CKD, older age and/or higher comorbidity burden, death and long-term care placement are markedly more likely than ESRD. Hence, clinicians, patients and families should all consider the relative magnitude of these risks when making decisions about renal replacement.
Keywords: albuminuria; chronic kidney disease; prognosis.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.Am J Kidney Dis. 2017 Sep;70(3):337-346. doi: 10.1053/j.ajkd.2017.01.050. Epub 2017 Mar 30. Am J Kidney Dis. 2017. PMID: 28366517 Free PMC article.
-
Comorbidity as a driver of adverse outcomes in people with chronic kidney disease.Kidney Int. 2015 Oct;88(4):859-66. doi: 10.1038/ki.2015.228. Epub 2015 Jul 29. Kidney Int. 2015. PMID: 26221754
-
Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.Nephrology (Carlton). 2017 Jan;22(1):25-34. doi: 10.1111/nep.12713. Nephrology (Carlton). 2017. PMID: 26718476
-
Cardiovascular disease in children with chronic kidney disease.J Am Soc Nephrol. 2012 Apr;23(4):578-85. doi: 10.1681/ASN.2011111115. Epub 2012 Mar 1. J Am Soc Nephrol. 2012. PMID: 22383696 Free PMC article. Review.
-
Adolescents and Young Adults with Chronic or End-Stage Kidney Disease.Blood Purif. 2016;41(1-3):205-10. doi: 10.1159/000441317. Epub 2016 Jan 15. Blood Purif. 2016. PMID: 26765837 Review.
Cited by
-
Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study.BMC Nephrol. 2019 Jun 6;20(1):204. doi: 10.1186/s12882-019-1351-9. BMC Nephrol. 2019. PMID: 31170925 Free PMC article.
-
Incidence, prevalence, and treatment of anemia of non-dialysis-dependent chronic kidney disease: A retrospective database study in France.PLoS One. 2023 Jul 5;18(7):e0287859. doi: 10.1371/journal.pone.0287859. eCollection 2023. PLoS One. 2023. PMID: 37406014 Free PMC article.
-
Regional burden of chronic kidney disease in North Africa and Middle East during 1990-2019; Results from Global Burden of Disease study 2019.Front Public Health. 2022 Oct 11;10:1015902. doi: 10.3389/fpubh.2022.1015902. eCollection 2022. Front Public Health. 2022. PMID: 36304241 Free PMC article.
-
Age and the eGFR-dependent risk for adverse clinical outcomes.Clin Kidney J. 2022 Sep 17;16(2):245-253. doi: 10.1093/ckj/sfac213. eCollection 2023 Feb. Clin Kidney J. 2022. PMID: 36755849 Free PMC article. Review.
-
Quantification of Inflammasome Adaptor Protein ASC in Biological Samples by Multiple-Reaction Monitoring Mass Spectrometry.Inflammation. 2018 Aug;41(4):1396-1408. doi: 10.1007/s10753-018-0787-6. Inflammation. 2018. PMID: 29948504
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical